Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices

Europace

Volumn 10, Issue 3, 2008, Pages 336-346

  Roguin, Ariel ^a   Schwitter, Juerg ^b   Vahlhaus, Christian ^c   Lombardi, Massimo ^d   Brugada, Josep ^e   Vardas, Panos ^f   Auricchio, Angelo ^g   Priori, Silvia ^h   Sommer, Torsten ⁱ  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^e UNIVERSITY OF BARCELONA   (Spain)

^f UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^g DIVISION OF CARDIOLOGY   (Switzerland)

^h UNIVERSITY OF PAVIA   (Italy)

ⁱ UNIVERSITY OF BONN   (Germany)

Author keywords

ICD; Imaging; MR imaging; Pacemaker; Safety

Indexed keywords

LEAD;

ARTIFICIAL HEART PACEMAKER; DEFIBRILLATOR; FORCE; HEALTH HAZARD; HEAT; HUMAN; IMAGE QUALITY; IN VITRO STUDY; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SAFETY; TECHNOLOGY; TORQUE;

ANIMALS; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EQUIPMENT SAFETY; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, ANIMAL; PACEMAKER, ARTIFICIAL;

EID: 44649139918     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun021     Document Type: Review

References (52)

1. Pinski SL, Trohman RG. Interference in implanted cardiac devices: Part II. Pacing Clin Electrophysiol 2002;25:1496-509.
2. Niehaus M, Tebbenjohanns J. Electromagnetic interference in patients with implanted pacemakers or cardioverter-defibrillators. Heart 2001;86:246-8.
3. Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ 2006;175:911-7.
4. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-9.
5. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
6. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-5.
7. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005;28:326-8.
8. Kanal E, Borgstede JP, Barkovich AJ et al. American College of Radiology-White Paper on MR safety: 2004 update and revisions. AJR 2004;182:1111-4.
9. Erlebacher JA, Cahill PT, Pannizzo F, Knowles JR. Effect of magnetic resonance imaging on DDD pacemakers. Am J Cardiol 1986;57:437-40.
10. Hayes DL, Vlictstra RE. Pacemaker malfunction. Am Coll Physicians 1993;119:828-35.
11. Pavlicek W, Geisinger M, Castle L, Borkowski GP, Meaney TF, Bream BL et al. The effects of NMR on patients with cardiac pacemakers. Radiology 1983;147:149-53.
12. Fetter J, Aram G, Holmes DR, Gray JE, Hayes DL. The effects of nuclear magnetic resonance imagers on external and implantable pulse generators. Pacing Clin Electrophysiol 1984;7:720-7.
13. Pohost GM, Blackwell GG, Shellock FG. Safety of patients with medical devices during application of magnetic resonance methods. Ann NY Acad Sci 1992;649:302-12.
14. Gimbel JR, Kanal E. Can patients with implantable pacemakers safely undergo magnetic resonance imaging? J Am Coll Cardiol 2004;43:1325-7.
15. Shellock FG, Crues JV III. MR safety and the American College of Radiology White Paper. AJR 2002;178:1349-52.
16. Irnich W, Irnich B, Bartsch C, Stertmann WA, Gufler H, Weiler G. Do we need pacemakers resistant to magnetic resonance imaging? Europace 2005;7:353-65.
17. Alagona P, Toole JC, Maniscalco BS, Glover MU, Abernathy GT, Prida XA. Nuclear magnetic resonance imaging in a patient with a DDD pacemaker. Pacing Clin Electrophysiol 1989;12:619-20.
18. Inbar S, Larson J, Burt T, Mafee M, Ezri MD. Case report: nuclear magnetic resonance imaging in a patient with a pacemaker. Am J Med Sci 1993;305:174-5.
19. Gimbel JR, Johnson D, Levine PA, Wilkoff BL. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol 1996;19:913-9.
20. Fontaine JM, Mohamed FB, Gottlieb C, Callans DJ, Marchlinski FE. Rapid ventricular pacing in a pacemaker patient undergoing magnetic resonance imaging. Pacing Clin Electrophysiol 1998;21:1336-9.
21. Garcia-Bolao I, Albaladejo V, Benito A, Alegria E, Zubieta JL. Magnetic resonance imaging in a patient with a dual-chamber pacemaker. Acta Cardiologia 1998;19:33-5.
22. Sommer T, Vahlhaus C, Lauck G, von Smekal A, Reinke M, Hofer U et al. MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology 2000;215:869-79.
23. Holmes DR, Hayes DL, Gray JE, Merideth J. The effects of magnetic resonance imaging on implantable pulse generators. Pacing Clin Electrophysiol 1986;9:360-70.
24. Lauck G, von Smekal A, Wolke S, Seelos KC, Jung W, Manz M et al. Effects of nuclear magnetic resonance imaging on cardiac pacemaker. Pacing Clin Electrophysiol 1995;18:1549-55.
25. Hayes DL, Holmes DR, Gray JE. Effect of 1.5 Tesla nuclear magnetic resonance imaging scanner on implated permanent pacemakers. J Am Coll Cardiol 1987;10:782-6.
26. Achenbach S, Moshage W, Diem B, Bieberle T, Schibgilla V, Bachmann K. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 1997;134:467-73.
27. Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004;110:475-82.
28. Schmiedel A, Hackenbroch M, Yang A, Nahle CP, Skowasch D, Meyer C et al. Magnetic resonance imaging of the brain in patients with cardiac pace makers. In-vitro- and in-vivo-evaluation at 1.5 Tesla. Rofo 2005;177:731-44.
29. Luechinger R, Zeijlemaker VA, Pedersen EM, Mortensen P, Falk E, Duru F et al. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J 2005;26:376-83.
30. Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R. Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol 2001;24:199-205.
31. Shinbane JS, Colletti PM, Shellock FG. MR in Patients with Pacemakers and ICDs: Defining the Issues. J Cardiovasc Magn Reson 2007;9:5-13.
32. Vahlhaus C, Sommer T, Lewalter T, Schimpf R, Schumacher B, Jung W et al. Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5 Tesla? Pacing Clin Electrophysiol 2001;24:489-95.
33. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004;43:1315-24.
34. Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 Tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 2006;114:1285-92.
35. Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 Tesla. Circulation 2006;114:1277-84.
36. Goldsher D, Amikam S, Boulos M, Suleiman M, Shreiber R, Eran A et al. Magnetic resonance imaging for patients with permanent pacemakers: initial clinical experience. Isr Med Assoc J 2006;8:91-4.
37. Gimbel JR, Bailey SM, Tchou PJ, Ruggieri PM, Wilkoff BL. Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients. Pacing Clin Electrophysiol 2005;28:1041-6.
38. Peden CJ, Collins AG, Butson PC, Whitwam JG, Young IR. Induction of microcurrents in critically ill patients in magnetic resonance systems. Crit Care Med 1993;21:1923-8.
39. Hartnell GG, Spence L, Hughes LA, Cohen MC, Saouaf R, Buff B. Safety of MR imaging in patients who have retained metallic materials after cardiac surgery. AJR 1997;168:1157-9.
40. Kanal E. Safety of MR imaging in patients with retained epicardial pacer wires (Letter). AJR 1998;170:213.
41. Naehle CP, Litt H, Lewalter T, Sommer T. Do we need pacemakers resistant to magnetic resonance imaging? Europace 2006;8:388.
42. Gimbel JR, Trohman RL, Lindsay WC, Wilckoff BL. Strategies for the safe performance of magnetic resonance imaging in selected ICD patients. Pacing Clin Electrophysiol 2002;25:618.
43. Anfinsen OG, Berntsen RF, Aass H, Kongsgaard E, Amile JP. Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging. Pacing Clin Electrophysiol 2002;25:1400-2.
44. Fiek M, Remp T, Reithmann C, Steinbeck G. Complete loss of ICD programmability after magnetic resonance imaging. Pacing Clin Electrophysiol 2000;27:1002-4.
45. Coman JA, Martin ET, Sandler DA, Pulling CC, Fair R, Jenkins K et al. Implantable cardiac defibrillator interactions with magnetic resonance imaging at 1.5 Tesla. J Am Coll Cardiol 2004;43:138A.
46. Naehle CP, Sommer T, Meyer C, Strach K, Kreuz J, Litt H et al. Strategy for safe performance of magnetic resonance imaging on a patient with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2006;29:113-6.
47. Wollmann C, Grude M, Tombach B, Kugel H, Heindel W, Breithardt G et al. Safe performance of magnetic resonance imaging on a patient with an ICD. Pacing Clin Electrophysiol 2005;28:339-42.
48. Roguin A, Donahue JK, Bomma CS, Bluemke DA, Halperin HR. Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator. Pacing Clin Electrophysiol 2005;28:336-8.
49. Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol 2005;28:270-3.
50. Loewy J, Loewy A, Kendall EJ. Reconsideration of Pacemakers and MR Imaging. Radiographics 2004;24:1257-67.
51. Schueler BA, Parrish TB, Lin J, Hammer BE, Pangrle BJ, Ritenour ER et al. MRI compatibility and visibility assessment of implantable medical devices. J Magn Reson Imaging 1999;9:596-603.
52. Faris OP, Shein M. Food and Drug Administration perspective: magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation 2006;114:1232-3.